Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 0.70 | 0.72 | 0.33 | 0.12 |
Depreciation/ Depletion | 0.01 | 0.00 | 0.01 | 0.01 |
Non- Cash Items | 0.41 | 0.42 | 0.41 | 0.47 |
Changesin Working Capital | 0.92 | -2.08 | 1.72 | -3.37 |
Cashfrom Operating Activities | 2.04 | -0.95 | 2.47 | -2.76 |
Capital Expenditures | -0.04 | 0.00 | 0.00 | -0.02 |
Other Investing Cash Flow Items Total | 0.00 | 0.00 | 0.00 | 0.00 |
Cashfrom Investing Activities | -0.04 | 0.00 | 0.00 | -0.02 |
Financing Cash Flow Items | -0.41 | -0.42 | -1.00 | -0.88 |
Issuance( Retirement)of Debt Net | -1.57 | 1.45 | -1.48 | 3.35 |
Cashfrom Financing Activities | -1.98 | 1.03 | -2.48 | 2.47 |
Net Changein Cash | 0.03 | 0.09 | -0.01 | -0.32 |
Cash Interest Paid | 0.41 | 0.42 | 0.41 | 0.47 |
Cash Taxes Paid | 0.15 | 0.12 | 0.00 | 0.05 |
Vivanza Biosciences Dividend Vivanza Biosciences Bonus Vivanza Biosciences News Vivanza Biosciences AGM Vivanza Biosciences Rights Vivanza Biosciences Splits Vivanza Biosciences Board Meetings Vivanza Biosciences Key Metrics Vivanza Biosciences Shareholdings Vivanza Biosciences Profit Loss Vivanza Biosciences Balance Sheet Vivanza Biosciences Q1 Results Vivanza Biosciences Q2 Results Vivanza Biosciences Q3 Results Vivanza Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks